Progress in Laser Treatment of Primary Cutaneous Amyloidosis

Primary cutaneous amyloidosis is a chronic disease characterized by amyloid protein deposition in normal skin. It not only affects skin appearance but also causes persistent itching, significantly impacting patients’ quality of life. Treatment options for this condition are diverse, encompassing pharmaceutical, physical, and surgical approaches. Currently, no standard treatment protocol exists, with choices often based on individual patient characteristics and physician experience. Laser technology, valued for its precision, minimally invasive nature, and safety profile, has gained increasing application in treating this condition, yielding notable efficacy and attracting widespread attention. This paper aims to provide a comprehensive review of the current status and future prospects of laser applications in the treatment of primary cutaneous amyloidosis.